Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 313

Showing 1-25 of 313 citing articles:

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
Nature (2022)
Open Access | Times Cited: 565
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 262
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 119-127
Open Access | Times Cited: 253
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 243
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
Cell Host & Microbe (2022) Vol. 31, Iss. 1, pp. 9-17.e3
Open Access | Times Cited: 242
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao, Fanchong Jian, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 211
Virological characteristics of the SARS-CoV-2 JN.1 variant
Yu Kaku, Kaho Okumura, Miguel Padilla‐Blanco, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 2, pp. e82-e82
Open Access | Times Cited: 210
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 178
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 175
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
Akatsuki Saito, Tomokazu Tamura, Jiří Zahradník, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1540-1555.e15
Open Access | Times Cited: 152
Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1
Linjie Li, Hanyi Liao, Yumin Meng, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2952-2960.e10
Open Access | Times Cited: 143
Antigenicity and infectivity characterisation of SARS-CoV-2 BA.2.86
Sijie Yang, Yuanling Yu, Fanchong Jian, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. e457-e459
Open Access | Times Cited: 143
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 137
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
Keiya Uriu, Jumpei Ito, Jiří Zahradník, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 280-281
Open Access | Times Cited: 125
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Jumpei Ito, Rigel Suzuki, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 121
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant
Keiya Uriu, Jumpei Ito, Yusuke Kosugi, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. e460-e461
Open Access | Times Cited: 121
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
Danyi Ao, Xuemei He, Weiqi Hong, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 109
Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study
Zhiyuan Chen, Xiaowei Deng, Li‐Qun Fang, et al.
The Lancet Regional Health - Western Pacific (2022) Vol. 29, pp. 100592-100592
Open Access | Times Cited: 101
Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant
Panke Qu, John P. Evans, Yi-Min Zheng, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 11, pp. 1518-1526.e4
Open Access | Times Cited: 91
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Hung Fu Tseng, Bradley K. Ackerson, Katia Bruxvoort, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 91
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies
Hao Zhou, Belinda M. Dcosta, Nathaniel R. Landau, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1334-1334
Open Access | Times Cited: 84
Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins
Youwei Xu, Canrong Wu, Xiaodan Cao, et al.
Cell Research (2022) Vol. 32, Iss. 7, pp. 609-620
Open Access | Times Cited: 82
Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines
Xin Zhao, Rong Zhang, Shitong Qiao, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 3, pp. 277-280
Open Access | Times Cited: 81
Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
Panke Qu, John P. Evans, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 80
Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
Kenrie P. Y. Hui, Ka‐Chun Ng, John CW Ho, et al.
EBioMedicine (2022) Vol. 83, pp. 104232-104232
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top